Nuvation Bio Inc (NUVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 125,391 | 164,086 | 98,897 | 247,970 | 47,977 |
| Marketable Securities | 408,338 | 365,125 | 450,148 | 359,752 | 413,699 |
| Receivables | 25,984 | 19,361 | 13,850 | 6,677 | 5,462 |
| Inventories | 15,844 | 11,411 | 5,710 | 552 | 14 |
| TOTAL | $591,529 | $571,519 | $577,530 | $623,208 | $475,567 |
| Non-Current Assets | |||||
| PPE Net | 535 | 564 | 560 | 615 | 562 |
| Intangibles | 10,755 | 11,214 | 11,680 | 12,145 | 4,410 |
| Other Non-Current Assets | 7,422 | 11,525 | 11,791 | 11,257 | 11,950 |
| TOTAL | $18,712 | $23,303 | $24,031 | $24,017 | $16,922 |
| Total Assets | $610,241 | $594,822 | $601,561 | $647,225 | $492,489 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,790 | 5,724 | 5,618 | 5,583 | 5,685 |
| Accounts payable and accrued liabilities | 22,435 | 9,479 | 15,360 | 22,419 | 10,537 |
| Accrued Expenses | 32,864 | 45,183 | 32,579 | 23,998 | 23,892 |
| Other current liabilities | 16,595 | 19,965 | 12,703 | 12,548 | 10,769 |
| TOTAL | $79,522 | $82,231 | $68,131 | $66,356 | $52,772 |
| Non-Current Liabilities | |||||
| Long Term Debt | 47,327 | 47,208 | 47,089 | 46,974 | N/A |
| Other Non-Current Liabilities | 163,828 | 159,667 | 160,459 | 160,988 | 20,257 |
| TOTAL | $211,155 | $206,875 | $207,548 | $207,962 | $20,257 |
| Total Liabilities | $290,677 | $289,106 | $275,679 | $274,318 | $73,029 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 348,202 | 347,597 | 342,833 | 342,273 | 340,263 |
| Common Shares | 1,431,214 | 1,421,273 | 1,404,799 | 1,396,220 | 1,382,894 |
| Retained earnings | -1,109,973 | -1,115,370 | -1,078,778 | -1,022,986 | -963,979 |
| Other shareholders' equity | -1,677 | -187 | -139 | -327 | 545 |
| TOTAL | $319,564 | $305,716 | $325,882 | $372,907 | $419,460 |
| Total Liabilities And Equity | $610,241 | $594,822 | $601,561 | $647,225 | $492,489 |